LONSURF 15/6.14 MG 20 F.C. TABS
سعر LONSURF 15/6.14 MG 20 F.C. TABS
10000.00 جنية
الشركة المنتجة لـ LONSURF 15/6.14 MG 20 F.C. TABS
TAIHO PHARMACEUTICAL CO. LTD. > SERVIER
المادة الفعالة LONSURF 15/6.14 MG 20 F.C. TABS
TRIFLURIDINE+TIPIRACIL
معلومات عن LONSURF 15/6.14 MG 20 F.C. TABS
LONSURF is indicated for the treatment of adult patients with metastatic gastric or gastroesophageal junction adenocarcinoma previously treated with at least two prior lines of chemotherapy that included a fluoropyrimidine a platinum either a taxane or irinotecan and if appropriate HER2/neu-targeted therapy.
